KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Capital Employed (2016 - 2025)

Fulgent Genetics' Return on Capital Employed history spans 10 years, with the latest figure at 0.01% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 5.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, up 5.0%, while the annual FY2025 figure was 0.01%, 5.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.01% at Fulgent Genetics, up from 0.06% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.86% in Q1 2021 and bottomed at 0.18% in Q3 2024.
  • The 5-year median for Return on Capital Employed is 0.05% (2023), against an average of 0.16%.
  • The largest annual shift saw Return on Capital Employed skyrocketed 86bps in 2021 before it tumbled -53bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.59% in 2021, then tumbled by -77bps to 0.14% in 2022, then crashed by -217bps to 0.16% in 2023, then soared by 60bps to 0.06% in 2024, then surged by 80bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Return on Capital Employed are 0.01% (Q4 2025), 0.06% (Q3 2025), and 0.06% (Q2 2025).